Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide identification of 5hmCpGs in multiple myeloma

ABSTRACT: Genome-wide identification of 5hmCpGs in multiple myeloma

PROVIDER: PRJNA510971 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8359320.fastq.gz	Fastqsanger.gz
	SRR8359330.fastq.gz	Fastqsanger.gz
	SRR8359340.fastq.gz	Fastqsanger.gz
	SRR8359321.fastq.gz	Fastqsanger.gz
	SRR8359331.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Genome-wide identification of 5hmCpGs in multiple myeloma

Project description:We report the genomic localization of 5-hydroxymethylcytosines in multiple myeloma patients through the use of selective chemical labeling (SCL) and exonuclease digestion. Data highlighted super-enhancers and enhancers specifically undergoing active DNA demethylation in multiple myeloma cells.

2019-07-08 | GSE124188 | GEO

Genome-wide screening of IKZF1 binding in multiple myeloma cells.

Project description:We analyzed genome-wide distribution of IKZF1 binding in multiple myeloma using ChIP-seq.

2022-01-30 | GSE194387 | GEO

Multiple myeloma

Project description:Multiple myeloma

| PRJNA515992 | ENA

Genome-wide screening of IKZF1 binding in multiple myeloma cells.

Project description:Genome-wide screening of IKZF1 binding in multiple myeloma cells.

| PRJNA800413 | ENA

Genome-wide maps of transcription in Multiple Myeloma cells treated with FHND004 or FHND008

Project description:FHND004 and FHND008 are newly synthesized epidermal growth factor receptor (EGFR) inhibitor for the treatment of non-small cell lung cancer (NSCLC), they were obtained on the basis of AZD9291. We found that FHND004 and FHND008 had a strong inhibitory effect on the proliferation of multiple myeloma cells in vitro. Genome-wide maps of transcription showed different genes change in Multiple Myeloma cells after 4μM FHND004 or FHND008 intervention.

2024-04-03 | GSE223166 | GEO

Genome wide association study on neuropathy in multiple myeloma

Project description:Performing GWAS on multiple myeloma in relation to the development of the toxicity neuropathy. This set was used as validation set. We performed a genome-wide association study using Affymetrix HD-SNP arrays 6.0 to identify risk variants for developing bortezomib-induced peripheral neuropathy (BiPN) in 469 multiple myeloma (MM) patients who received bortezomib-dexamethasone therapy prior to autologous stem-cell transplantation and conducted validation in an independent cohort of 116 MM patients. We identified one previously unreported BiPN risk locus at 21q22.3 (rs2839629, PKNOX1; OR = 0.53, 95% CI: [0.40-0.69]). PKNOX1 is known to regulate MCP-1, a potent mediator of chemotherapy-induced peripheral neuropathy. rs2839629 is in strong linkage disequilibrium ( r2 = 0.87) with rs915854, localized 6.5kb centromeric to CBS encoding endogenous H2S-producing enzyme. CBS-H2S signalling pathway is implicated in the pathogenesis of a variety of neurodegenerative and inflammatory disorders, and specifically in neuropathy models. Our data provide conclusive evidence for genetic susceptibility to BiPN in MM and new potential targets in neuro-protective strategies of treatment.

2016-06-01 | GSE66903 | GEO

Multiple Myeloma cells

Project description:Multiple Myeloma cells

| PRJNA800411 | ENA

Clonal competition with alternating dominance in multiple myeloma [GEP]

Project description:Copy number and expression profiling of multiple myeloma patients at multiple stages of their individual clinical course Identification of evolutionary patterns in multiple myeloma

2012-03-28 | GSE36824 | GEO

Clonal competition with alternating dominance in multiple myeloma [44kCGH]

Project description:Copy number and Gene expression profiling multiple myeloma patients at multiple stages of their individual clinical course Identification of evolutionary paterns in multiple myeloma

2012-03-28 | GSE36823 | GEO

Clonal competition with alternating dominance in multiple myeloma [244kCGH]

2012-03-28 | GSE36822 | GEO